Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancer

1989 ◽  
Vol 25 (4) ◽  
pp. 651-654 ◽  
Author(s):  
Kerry J. Walker ◽  
Richard F. Walker ◽  
Atilla Turkes ◽  
John F.R. Robertson ◽  
Roger W. Blamey ◽  
...  
1987 ◽  
Vol 28 ◽  
pp. 100
Author(s):  
G. Mathe ◽  
R. Helling ◽  
J. Gastlaburu ◽  
M.L.. VoVan ◽  
G. Prévot ◽  
...  

1989 ◽  
Vol 14 (3) ◽  
pp. 289-298 ◽  
Author(s):  
Andrea Manni ◽  
Alice E. Boucher ◽  
Laurence M. Demers ◽  
Harold A. Harvey ◽  
Allan Lipton ◽  
...  

1998 ◽  
Vol 4 (2) ◽  
pp. 116-120
Author(s):  
Raquel Gerson ◽  
Victor Lira-Puerto ◽  
Ernesto Sanchez-Forgach ◽  
Maria Teresa Ramirez ◽  
Aura Erazo ◽  
...  

1988 ◽  
Vol 24 (3) ◽  
pp. 417-421 ◽  
Author(s):  
P.H.B. Willemse ◽  
L.D. Dikkeschei ◽  
N.H. Mulder ◽  
E. Van Der Ploeg ◽  
D.TH. Sleijfer ◽  
...  

1986 ◽  
Vol 22 (6) ◽  
pp. 723 ◽  
Author(s):  
G. Mathé ◽  
R. Kelling ◽  
M.L. VoVan ◽  
J. Gastiaburu ◽  
G. Prévot ◽  
...  

1983 ◽  
Vol 69 (4) ◽  
pp. 343-347 ◽  
Author(s):  
Ferdinando Preda ◽  
Sara Oriana ◽  
Giovanni Di Fronzo ◽  
Giorgio Secreto ◽  
Aldo Severini ◽  
...  

Thirty-five premenopausal patients with metastasized or locally advanced breast cancer underwent ovariectomy. At relapse, after surgery, they were treated with hormone therapy or chemotherapy, according to hormonal tests carried out before the castration. Five-year survival, computed with the actuarial method, confirmed the better prognosis of the hormone-dependent patients and also an improved prognosis in the patients treated with hormone therapy after ovariectomy. Furthermore, chemotherapy proved more efficacious: an increased survival was observed in the non-hormone-dependent patients.


1979 ◽  
Vol 12 (4) ◽  
pp. 333-341 ◽  
Author(s):  
Hwee-Yong Yap ◽  
Gabriel N. Hortobagyi ◽  
George R. Blumenschein ◽  
Charles K. Tashima ◽  
Aman U. Buzdar ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document